Edition:
United Kingdom

Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,664JPY
16 Nov 2018
Change (% chg)

¥2 (+0.15%)
Prev Close
¥1,662
Open
¥1,682
Day's High
¥1,687
Day's Low
¥1,661
Volume
3,449,800
Avg. Vol
6,788,039
52-wk High
¥2,056
52-wk Low
¥1,380

Chart for

About

Astellas Pharma Inc. is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea, Taiwan and other markets through its subsidiaries. Its main... (more)

Overall

Beta: 0.60
Market Cap(Mil.): ¥3,012,207.00
Shares Outstanding(Mil.): 2,068.82
Dividend: 18.00
Yield (%): 2.34

Financials

  4503.T Industry Sector
P/E (TTM): 15.71 31.23 33.59
EPS (TTM): 92.68 -- --
ROI: 13.91 15.57 15.05
ROE: 15.50 16.94 16.62

Pfizer, Astellas revise two cancer drug trial protocols to speed up results

Drugmakers Pfizer Inc and Astellas Pharma Inc said on Wednesday they would change protocols for two late-stage trials testing prostate cancer drug Xtandi to speed up completion.

22 Aug 2018

Pfizer, Astellas revise two cancer drug trial protocols to speed up results

Drugmakers Pfizer Inc and Astellas Pharma Inc said on Wednesday they would change protocols for two late-stage trials testing prostate cancer drug Xtandi to speed up completion.

22 Aug 2018

Pfizer, Astellas revise two cancer drug trial protocols to speed up results

Aug 22 Drugmakers Pfizer Inc and Astellas Pharma Inc said on Wednesday they would change protocols for two late-stage trials testing prostate cancer drug Xtandi to speed up completion.

22 Aug 2018

Earnings vs. Estimates